Only QuikClot® hemostatic devices contain kaolin, proven to accelerate natural clotting and stop bleeding fast.1-5

Hospital

Achieves hemostasis efficiently when time is a factor1-5

Learn more

EMS/First Responders

Controls hemorrhaging when every moment counts1-5

Learn more

Law Enforcement

Stops bleeding fast until advanced medical help arrives1-5

Learn more

Military

The #1 hemostatic device for all 5 US military branches6

Learn more

References: 1. Trabattoni D, Montorsi P, Fabbiocchi F, Lualdi A, Gatto P, Bartorelli A. A new kaolin-based haemostatic bandage compared with manual compression for bleeding control after percutaneous coronary procedures. Eur Radiol. 2011;21:1687-1691. 2. Politi L, Aprile A, Paganelli C, et al. Randomized clinical trial on short-time compression with kaolin-filled pad: a new strategy to avoid early bleeding and subacute radial artery occlusion after percutaneous coronary intervention. J Interven Cardiol. 2011;24:65-72. 3. Trabattoni D, Gatto P, Bartorelli A. A new kaolin-based hemostatic bandage use after coronary diagnostic and interventional procedures. Int J Cardiol. 2012;156(1):53-54. 4. Lamb KM, Pitcher HT, Cavarocchi NC, Hirose H. Vascular site hemostasis in percutaneous extracorporeal membrane oxygenation therapy. Open Cardiovasc Thorac Surg J. 2012;5:8-10. 5. Pahari M, Moliver R, Lo D, Pinkerton D, Basadonna G. QuikClot® Interventional™ Hemostatic Bandage (QCI): a novel hemostatic agent for vascular access. Cath Lab Digest. 2010;18(1):28-30. http://www.cathlabdigest.com/articles/QuikClot®-Interventional™-Hemostatic-Bandage-QCI-A-Novel-Hemostatic-Agent-Vascular-Access. Accessed on August 10, 2014. 6. Tactical Combat Casualty Care Guidelines 2014. http://www.itstactical.com/wp-content/uploads/2014/07/TCCC-Guidelines-update-june-2-2014.pdf. Accessed September 16, 2014. 7. QuikClot Material Safety Data Sheet (MSDS), http://www.unimedcorp.com/MSDS/MSDS_QuikClotCombatGauze.pdf. Updated August 14, 2008. Accessed September 12, 2014. 8. QuikClot lnterventional-A Hemostatic Bandage 510(k) Summary. US Food and Drug Administration. Updated March 11, 2013. http://www.accessdata.fda.gov/cdrh_docs/pdf12/k120782.pdf. Accessed September 12, 2014. 9. Ilesanmi OO. Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy. http://openi.nlm.nih.gov/detailedresult.php?img=3222266_hr-2010-1-e2-g008&req=4. Accessed September 13, 2014. 10. Curry N, Hopewell S, Dorée C, Hyde C, Brohi K, Stanworth S. The acute management of trauma hemorrhage: a systematic review of randomized controlled trials. Crit Care. 2011;15(2):R92. 11. Kheirabadi BS, Mace JE, Terrazas IB, et al. Safety evaluation of new hemostatic agents, smectite granules, and kaolin-covered gauze in a vascular injury wound model in swine. J Trauma. 2010;68:269-278. 12. Kheirabadi BS, Scherer MR, Estep JS, Dubick MA, Holcomb JB. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine. J Trauma. 2009;67:450-460. 13. Kheirabadi BS. Evaluation of topical hemostatic agents for combat wound treatment. US Army Med Dep J. 2011;25-37.

Show ReferencesHide References


 

Our site includes links to third party sites in which the Z-Medica® Privacy Policy and Terms of Use do not apply. Please read the privacy policy for every third party website you visit.

Continue